Commitments and Contingencies (Details) - USD ($) |
1 Months Ended | 3 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Mar. 11, 2022 |
Nov. 01, 2021 |
Aug. 04, 2021 |
Apr. 09, 2021 |
Sep. 21, 2021 |
Mar. 31, 2022 |
Mar. 31, 2021 |
Jan. 26, 2022 |
Jul. 13, 2020 |
|
| Commitments and Contingencies (Details) [Line Items] | |||||||||
| Description of medical office lease | (i) the first Monday after the landlord completes the tentant improvements as specified in the agreement or (ii) April 1, 2022. The lease has a 60-month term, and the Company has an option to extend the term for one 5-year renewal period at the prevailing market rate that the landlord is then obtaining from tenants for comparable space in the building. The lease has a base monthly rent of $8,336 per month for the first 12 months, with the base monthly rent increasing by 4% on the first anniversary of the lease commencement date and every 12 months thereafter. In addition to the base monthly rent, commencing on the first anniversary of the lease commencement date, the Company will pay its share of certain direct operating and tax expenses incurred by the landlord in maintaining the building. | ||||||||
| Consulting agreement annual salary | $ 120,000 | ||||||||
| Annually services | $ 50,000 | ||||||||
| Gain on forgiveness of accounts payable | $ 45,000 | ||||||||
| Agreement Description | The agreement includes a base salary of $450,000 per year, Sign-on bonus of $100,000, paid in a lump sum after January 1, 2022, and eligibility for an annual discretionary bonus of up to 75% of the base salary. The 2021 Employment Agreement also included an option to purchase 200,000 shares of the Company’s common stock, subject to approval by the Board of Directors, which include a three year vesting schedule, under which 33% of the total shares subject to the Option will vest 12 months after the vesting commencement date (which will be grant date), and the remainder shall vest in equal tranches quarterly thereinafter until either the Option is fully vested or Executive’s Continuous Service (as defined in the Plan) terminates, whichever occurs first. | ||||||||
| Employee vesting period, description | The RSU’s shall vest over 3 years with 33 and 1/3% vesting on the employees first anniversary and then quarterly then after over the remaining vesting period. The anticipated RSUs will be governed by the terms and conditions of the Plan and Executive’s grant agreement (the “RSU Agreement”), and will include a three year vesting schedule, under which 33% of the RSUs will vest 12 months after the vesting commencement date (which will be grant date), and the remainder shall vest in equal tranches quarterly thereinafter until either the RSUs are fully vested or Executive’s Continuous Service (as defined in the Plan) terminates, whichever occurs first. | ||||||||
| Dr. Tiago Reis Marques [Member] | |||||||||
| Commitments and Contingencies (Details) [Line Items] | |||||||||
| Annual base salary | $ 120,000 | ||||||||
| Financing over the terms of employment agreement | $ 5,000,000 | ||||||||
| Board of Directors Chairman [Member] | |||||||||
| Commitments and Contingencies (Details) [Line Items] | |||||||||
| Restricted stock (in Shares) | 200,000 | ||||||||
| Zen Baker Street Clinic [Member] | |||||||||
| Commitments and Contingencies (Details) [Line Items] | |||||||||
| Percentage of revenues from treatments | 30.00% | ||||||||
| Zen Knightsbridge Clinic [Member] | |||||||||
| Commitments and Contingencies (Details) [Line Items] | |||||||||
| Percentage of revenues from treatments | 30.00% | ||||||||
| Business Support Services Subcontract [Member] | |||||||||
| Commitments and Contingencies (Details) [Line Items] | |||||||||
| Subcontract effective term | 15 years | ||||||||
| Subcontract fees | $ 22,500 | ||||||||
| Aptuit (Verona) Srl [Member] | |||||||||
| Commitments and Contingencies (Details) [Line Items] | |||||||||
| Description of integrated research and development agreement | Evotec will provide integrated drug discovery and development research services for the Company over a period of approximately 39 months. Under the agreement, the Company will incur full-time equivalent employee (FTE)-based costs at a rate of $275,000 per FTE per annum for all services, excluding program specific materials which are estimated to be approximately an additional 10% of the total FTE-based price. In addition to the FTE-based costs, the Company shall make milestone payments of up to $6.25 million subject to the successful progression to the next stage of research as agreed to by a joint steering committee. The dollar amounts in the agreement are also subject to adjustment on an annual basis, starting January 1, 2023, for inflation based on a published consumer price index. | ||||||||
| Portman [Member] | Zen Baker Street Clinic [Member] | |||||||||
| Commitments and Contingencies (Details) [Line Items] | |||||||||
| Percentage of revenues from treatments | 70.00% | ||||||||
| Purecare [Member] | Zen Knightsbridge Clinic [Member] | |||||||||
| Commitments and Contingencies (Details) [Line Items] | |||||||||
| Percentage of revenues from treatments | 70.00% | ||||||||